Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Read more
Sign In
June 18, 20215:13 AM PDTLast Updated a month ago
Healthcare & Pharmaceuticals
S.Korea pledges $200 million to international COVID-19 vaccine effort

2 minute read
A woman wearing a mask amid the coronavirus disease (COVID-19) pandemic takes photographs of her boyfriend at a Han river park in Seoul, South Korea, May 24, 2021. REUTERS/Kim Hong-Ji/File Photo
SEOUL, June 18 (Reuters) - South Korea has pledged to donate a total of $200 million to the COVAX programme that is supplying coronavirus vaccines for lower-income countries, the Global Alliance for Vaccines and Immunization (GAVI) said on Friday.
COVAX, backed by GAVI and the World Health Organization (WHO), aims to secure 2 billion vaccine doses by the end of 2021. read more
“The Republic of Korea pledges a contribution of a total of $100 million this year, and in 2022 another $100 million in the form of a combination of financial and in-kind contribution,” South Korean President Moon Jae-in said in a statement by GAVI.
While wealthy nations with robust vaccination campaigns have inoculated large swaths of their population, much of the world lags far behind, raising concerns of more COVID-19 waves that could spawn new virus variants.
Leaders from the Group of Seven rich nations agreed over the weekend to pledge 870 million vaccine doses, with the aim of delivering at least half by the end of this year. WHO Director-General Tedros Adhanom Ghebreyesus welcomed this on Monday but said many more doses were needed and quickly. read more
Reporting by Heekyong Yang Editing by Frances Kerry
Our Standards: The Thomson Reuters Trust Principles.
More from Reuters
Play video on original page
Read Next
South Africa lifts some coronavirus restrictions after cases drop
1:10 PM PDT
United States
U.S. administers 341.8 mln doses of COVID-19 vaccines
11:35 AM PDT
Italy reports seven more coronavirus deaths, 4,743 new infections
10:56 AM PDT
United Kingdom
Britain reports 29,173 COVID-19 cases on Sunday, lower than a day earlier
10:06 AM PDT

Sign up for our newsletter
Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
Healthcare & Pharmaceuticals
Healthcare & Pharmaceuticals · 9:19 AM PDT
Some Americans could need COVID-19 vaccine booster -Fauci
Top infectious disease official Anthony Fauci said on Sunday that Americans who are immune compromised may end up needing COVID-19 vaccine booster shots as the United States deals with increasing cases from the Delta variant of the coronavirus.
Healthcare & Pharmaceuticals
Vietnam says more U.S. vaccine donations expected after first 5 mln doses
5:29 AM PDT
Healthcare & Pharmaceuticals
Merkel aide warns virus surge in Germany may mean curbs for unvaccinated
6:27 AM PDT
Healthcare & Pharmaceuticals
South Korea steps up COVID-19 curbs ahead of peak holiday season
3:19 AM PDT
Healthcare & Pharmaceuticals
Asian COVID epicentre of Indonesia extends curbs by a week
8:36 AM PDT
About Reuters
About Reuters
Reuters News Agency
Brand Attribution Guidelines
Reuters Leadership
Reuters Fact Check
Reuters Diversity Report
Stay Informed
Download the App
Information you can trust
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Follow Us
Thomson Reuters Products
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Refinitiv Products
Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface.
Refinitiv Data Platform
Access to real-time, reference, and non-real time data in the cloud to power your enterprise.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
Advertise With Us
Advertising Guidelines
Terms of Use
Site Feedback

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All rights reserved